# Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19

> **NCT04345406** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Tanta University** · enrollment: 60 (estimated)

## Conditions studied

- COVID

## Interventions

- **DRUG:** ACEIs
- **DRUG:** Conventional treatment

## Key facts

- **NCT ID:** NCT04345406
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2020-04-15
- **Primary completion:** 2029-12-01
- **Final completion:** 2029-12-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2020-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04345406

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04345406, "Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04345406. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*